HOME >> BIOLOGY >> NEWS
Enzyme once thought harmful to Alzheimers patients now appears key to future treatment

March 12, 2002 -- Bethesda, MD -- The four million Americans who have been diagnosed with Alzheimers disease (AD) experience symptoms which include progressive mental deterioration, confusion, a loss of memory and an inability to calculate the simplest of numbers. This may be due to the fact that people with Alzheimer's have fewer brain cells and less of some important neurotransmitters than people without the disease.

The Importance of Galanin
Previous research has established that a substance called galanin is associated with learning and memory and is involved in brain function, and disorders such as epilepsy. When a nerve is cut or injured, the neuron produces extra galanin, possibly to repair or modulate the damage. The production of galanin may be one way that the body tries to repair nerve damage. Unfortunately, accepted literature states when the onset of AD occurs, galanin hyperinnervation (excessive supply) of nerve cells that employ acetylcholine as their neurotransmitter in the basal forebrain of AD patients occurs and depresses acetylcholine release and its inhibitory actions at other central nervous system sites.

Background
The majority of the scientific community believes this action is detrimental. This is due to a finding that AD wipes out many of the cholinergic neurons of the hippocampus; those that survive in the nucleus show elevated expression of galanin. However, a new study suggests that by virtue of its excitatory actions on cholinergic neurons, galanin may in fact play a compensatory role by enhancing the release of acetylcholine from remaining cholinergic basal forebrain neurons. This action might serve to delay the progression of Alzheimer's disease linked to a reduction in central cholinergic tone. This raises the possibility that induction of galanin by nerve growth factor may have a neuroprotective role.

The Study
To examine this theory, an investigation of the mechanism of action of this
'"/>

Contact: Donna Krupa
djkrupa1@aol.com
703-527-7357
American Physiological Society
14-Mar-2002


Page: 1 2 3

Related biology news :

1. Enzyme maintaining chromosome ends is linked to bone cancer recurrence, decreased survival
2. Enzyme activation appears key in helping internal clock tell night from day
3. Enzyme fully degrades mad cow disease prion
4. Enzyme revealed that is key to funguss ability to breach immune system
5. Enzyme discovery sheds light on causes of rare disease, cancer
6. Enzyme could overcome industrial bleaching waste problems
7. Enzyme controls good cholesterol
8. Enzyme discovery to benefit homeland security, industry
9. Enzyme could aid cancer fight
10. Enzyme mimetic reduces tissue damage in colitis animal study
11. Enzyme studies at Brookhaven Lab may lead to new antiviral agents

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/18/2018)... ... October 18, 2018 , ... ... industry, announces the grand opening of its new West Cambridge flagship facility scheduled ... rental suites, a wet lab, tissue culture, necropsy and surgery rooms will give ...
(Date:10/18/2018)... ... October 18, 2018 , ... Protein derived from cottonseed for ... approval , Writer: Kay Ledbetter, 806-677- 5608, skledbetter@ag.tamu.edu, Dr. Keerti Rathore, 979-862-4795, rathore@tamu.edu ... project to which Dr. Keerti Rathore has devoted more than half his professional ...
(Date:10/16/2018)... ... October 16, 2018 , ... ... software solutions for biopharmaceutical R&D, today announced Genedata Imagence®, the industry’s first ... images. The deep learning-based solution accelerates, by orders of magnitude, the time-consuming ...
Breaking Biology News(10 mins):
(Date:10/18/2018)... ... October 18, 2018 , ... Predicine, ... the San Francisco Bay Area has received accreditation from the College of American ... , Predicine received CAP accreditation for its Shanghai facility last month. The current ...
(Date:10/17/2018)... , ... October 17, 2018 , ... ... and development solutions for drugs, biologics and consumer health products, today announced that ... Delivery Institute, will present at the annual Partnership Opportunities in Drug Delivery (PODD) ...
(Date:10/16/2018)... ... October 16, 2018 , ... Infinity Healing Center, ... on a revolutionary technology that effectively treats pain, reduces the need for opioids, ... on how technology using photobiomodulation (PBM) has been effective for the treatment of ...
(Date:10/13/2018)... ... October 12, 2018 , ... The Laser ... and commercialization, celebrates its 50th birthday in New York’s Times Square today, ahead ... (ICALEO) conference. , In celebration of its 50 years, LIA showed thanks ...
Breaking Biology Technology:
Cached News: